SCHEMBL27880908

SCHEMBL27880908

CCCCCCO[Si](C)(C)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 1/20 0.43
LPAR3 Q9UBY5 6/20 0.41
LPAR2 Q9HBW0 5/20 0.41
LPAR1 Q92633 2/20 0.41
NAAA Q02083 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
CES2 O00748 1/20 0.40
TSHR P16473 1/20 0.40
GBA1 P04062 1/20 0.40
EPHX1 P07099 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
LMNA P02545 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14777016 0.90
SCHEMBL1276157 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL28413946 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL28055614 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL10438599 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL25191483 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL8955296 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL1157411 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL29010387 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT
SCHEMBL27799298 0.82 THRB (0.44) THRBMEN1KMT2AHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102786534-A Preparation method of everolimus SHANGSHAI SHYNDEC PHARMACEUTICAL CO LTD 2012-11-21 CN disclosed
CN-102786534-A Preparation method of everolimus SHANGSHAI SHYNDEC PHARMACEUTICAL CO LTD 2012-11-21 CN disclosed